Literature DB >> 11143311

Functional organization of the human masseter muscle.

J F Gaudy1, A Zouaoui, P Bravetti, J L Charrier, A Guettaf.   

Abstract

The authors carried out an anatomic and magnetic resonance imaging study of the architecture of the elevator muscles of the mandible in 169 cadavers. The aim of this study was to define the architectural organization of the human masseter muscle, temporalis and pterygoid muscles. Layered dissections and anatomic sections in different spatial planes showed that the masseter muscle exhibited a typical pennate structure consisting of a succession of alternating musculoaponeurotic layers. The muscle had three well-differentiated parts: the superficial, intermediate and deep masseter muscles. The same pattern was constantly found: 1) for the superficial masseter, two alternate musculoaponeurotic layers oriented at 60 degrees in relation to the plane of occlusion, 2) for the intermediate masseter, a single musculo-aponeurotic layer oriented at 90 degrees in relation to the occlusal plane, 3) for the deep masseter, three musculoaponeurotic layers whose general orientation was at 90 degrees for the bounding layers and 110 degrees for the intermediate layer. The MRI study confirmed the reality of this architectural arrangement.

Entities:  

Mesh:

Year:  2000        PMID: 11143311     DOI: 10.1007/s00276-000-0181-5

Source DB:  PubMed          Journal:  Surg Radiol Anat        ISSN: 0930-1038            Impact factor:   1.246


  11 in total

1.  Histological study of the human temporo-mandibular joint and its surrounding muscles.

Authors:  P Bravetti; H Membre; A El Haddioui; H Gérard; J P Fyard; P Mahler; J F Gaudy
Journal:  Surg Radiol Anat       Date:  2004-10       Impact factor: 1.246

2.  Masseter muscle termination over the deep surface of the temporal fascia: look out the wrong path.

Authors:  Pierre Guerreschi; Thomas Gahagnon; Christian Vacher; Antoine Drizenko; Jean-Paul Francke; Daniel Labbe
Journal:  Surg Radiol Anat       Date:  2011-10-20       Impact factor: 1.246

3.  Functional anatomy of the human lateral pterygoid muscle.

Authors:  A El Haddioui; F Laison; A Zouaoui; P Bravetti; J F Gaudy
Journal:  Surg Radiol Anat       Date:  2005-10-01       Impact factor: 1.246

Review 4.  Effects of physical training and detraining, immobilisation, growth and aging on human fascicle geometry.

Authors:  Anthony J Blazevich
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Anatomical study of the arrangement and attachments of the human medial pterygoid muscle.

Authors:  Aziz El Haddioui; P Bravetti; J-F Gaudy
Journal:  Surg Radiol Anat       Date:  2007-02-23       Impact factor: 1.246

6.  Validity and reliability of masseter muscles segmentation from the transverse sections of Cone-Beam CT scans compared with MRI scans.

Authors:  Yichen Pan; Yinghui Wang; Gang Li; Si Chen; Tianmin Xu
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-10-08       Impact factor: 2.924

7.  General organization of the human intra-masseteric aponeuroses: changes with ageing.

Authors:  G Brunel; A El-Haddioui; P Bravetti; A Zouaoui; J-F Gaudy
Journal:  Surg Radiol Anat       Date:  2003-09-06       Impact factor: 1.246

8.  Activation properties of trigeminal motoneurons in participants with and without bruxism.

Authors:  Jessica M D'Amico; Ş Utku Yavuz; Ahmet Saraçoglu; Elif Sibel Atiş; Monica A Gorassini; Kemal S Türker
Journal:  J Neurophysiol       Date:  2013-09-25       Impact factor: 2.714

9.  The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection.

Authors:  Hyung-Jin Lee; In-Won Kang; Kyle K Seo; You-Jin Choi; Seong-Taek Kim; Kyung-Seok Hu; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2016-12-30       Impact factor: 4.546

10.  Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.

Authors:  Kyu-Lim Lee; Hyun Jin Cho; Hyungkyu Bae; Hyun Jin Park; Min Sun Park; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2020-03-22       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.